BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/29/2014 7:34:00 PM | Browse: 916 | Download: 1060
Publication Name World Journal of Gastroenterology
Manuscript ID 11059
Country China
Received
2014-05-02 13:21
Peer-Review Started
2014-05-02 13:34
To Make the First Decision
2014-06-10 13:21
Return for Revision
2014-06-18 16:34
Revised
2014-06-29 19:55
Second Decision
2014-07-16 12:59
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-07-16 13:12
Articles in Press
2014-07-16 17:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-07-23 20:57
Typeset the Manuscript
2014-10-17 11:40
Publish the Manuscript Online
2014-10-29 19:34
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Biochemistry & Molecular Biology
Manuscript Type Autobiography
Article Title Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells
Manuscript Source Unsolicited Manuscript
All Author List Ru-Yi Chen, Bin Xu, Su-Feng Chen, Si-Si Chen, Ting Zhang, Jun Ren and Jian Xu
Funding Agency and Grant Number
Funding Agency Grant Number
Qianjiang Talent Project of Zhejiang Province 2013R10072
Natural Science Foundation of Zhejiang Province LY14H160037
Natural Science Foundation of Zhejiang Province LY12H16007
Corresponding Author Jian Xu, PhD, Associate Professor, The College of Life Science, Zhejiang Chinese Medical University, Bin Wen Road, Bin Jiang District, Hangzhou 310053, Zhejiang Province, China. xujian832002@163.com
Key Words Pancreatic cancer; Hallmarks; Oridonin; Inflammatory pathways; Nuclear transcription factors
Core Tip Pancreatic cancer is a common cancer of the digestive system and is a leading cause of morbidity and mortality worldwide. In this report, we demonstrate that oridonin is able to inhibit the growth of human pancreatic cancer (BxPC-3) cells and change the expression of cancer hallmark-related proteins. Inflammatory factors were decreased in BxPC-3 cells treated with oridonin, and oridonin also regulated nuclear transcription factor pathways. We propose that oridonin can reduce growth, metastasis, and angiogenesis in BxPC-3 cells by regulating the nuclear transcription factor-mediated expression of related inflammatory factors.
Publish Date 2014-10-29 19:34
Citation Chen RY, Xu B, Chen SF, Chen SS, Zhang T, Ren J, Xu J. Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells. World J Gastroenterol 2014; 20(40): 14895-14903
URL http://www.wjgnet.com/1007-9327/full/v20/i40/14895.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i40.14895
Full Article (PDF) WJG-20-14895.pdf
Full Article (Word) WJG-20-14895.doc
Manuscript File 11059-Review.doc
Answering Reviewers 11059-Answering reviewers.pdf
Copyright License Agreement 11059-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 11059-Language certificate.pdf
Peer-review Report 11059-Peer reviews.pdf
Scientific Misconduct Check 11059-CrossCheck.jpg
Scientific Editor Work List 11059-Scientific editor work list.pdf